BTCYOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31
BIOTRICITY INC.
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$0.05+0.00 (+8.70%)
Close on Oct 19, 2026
- Market cap
- $1.15M
- P/E (TTM)
- –
- Dividend yield
- –
Biotricity statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | Biotricity | Industry median |
|---|---|---|
| Market Cap | $995.70K | $230.55M |
| Enterprise Value | $529.20K | $202.97M |
| PS Ratio | 0.06 | 3.11 |
| P/OCF Ratio | 6.16 | 22.35 |
Enterprise value
| Measure | Biotricity | Industry median |
|---|---|---|
| EV / Sales | 0.03 | 2.92 |
| EV / EBITDA | 0.34 | 19.86 |
| EV / EBIT | 0.34 | 24.88 |
Income (trailing twelve months)
| Measure | Biotricity | Industry median |
|---|---|---|
| Revenue | $16.40M | $102.39M |
| Gross Profit | $13.36M | $60.36M |
| Operating Income | $1.57M | -$4.31M |
| Pretax Income | -$2.69M | -$2.26M |
| Net Income | -$2.69M | -$6.57M |
| EBITDA | $1.57M | -$1.98M |
| EPS (Diluted) | -$0.14 | -$0.07 |
Margins
| Measure | Biotricity | Industry median |
|---|---|---|
| Gross Margin | 81.5% | 55.1% |
| Operating Margin | 9.56% | -6.04% |
| Pretax Margin | -16.4% | -4.11% |
| Profit Margin | -16.4% | -10.5% |
| EBITDA Margin | 9.56% | -2.67% |
Returns
| Measure | Biotricity | Industry median |
|---|---|---|
| Return on Assets (ROA) | -44.6% | -13.3% |
Growth
| Measure | Biotricity | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 13.4% | 8.85% |
| Revenue Growth (3Y CAGR) | 18.4% | 7.08% |
| Revenue Growth (5Y CAGR) | 36.4% | 11.8% |
Balance sheet
| Measure | Biotricity | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $466.50K | $37.33M |
| Net Cash (Debt) | $466.50K | $3.92M |
| Net Cash Per Share | $0.02 | $0.28 |
| Equity (Book Value) | -$35.41M | $57.36M |
| Book Value Per Share | -$1.78 | $2.81 |
| Tangible Book Value | -$35.41M | $10.71M |
| Working Capital | -$31.75M | $54.64M |
Financial position
| Measure | Biotricity | Industry median |
|---|---|---|
| Current Ratio | 0.15 | 2.50 |
| Quick Ratio | 0.08 | 1.54 |
| Interest Coverage | 0.47 | -1.81 |
Cash flow (trailing twelve months)
| Measure | Biotricity | Industry median |
|---|---|---|
| Operating Cash Flow | $161.66K | -$653.46K |
Efficiency
| Measure | Biotricity | Industry median |
|---|---|---|
| Asset Turnover | 2.72 | 0.59 |
| Inventory Turnover | 1.89 | 2.21 |
| Revenue Per Employee | $356.55K | $322.57K |
| Profits Per Employee | -$58.51K | -$51.88K |
| Employee Count | 46 | 185 |
Dividends and yields
| Measure | Biotricity | Industry median |
|---|---|---|
| Earnings Yield | -270.3% | -6.91% |
Shares
| Measure | Biotricity | Industry median |
|---|---|---|
| Shares Outstanding | 19,914,000 | 44,856,700 |
| Shares Change (YoY) | 6.70% | 3.35% |
| Shares Change (QoQ) | -29.8% | 0.27% |
| Float | 19,914,000 | 37,097,900 |
| Shares Held by Insiders | 0.00% | 10.6% |
| Shares Held by Institutions | 0.24% | 63.5% |
Scores
| Measure | Biotricity | Industry median |
|---|---|---|
| Altman Z-Score | -36.11 | 1.95 |
| Piotroski F-Score | 5 | 5 |
Calculated by StockData from Biotricity's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.